Opportunity ID: 267948

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-HL-15-024
Funding Opportunity Title: Definition of Resilience and Pre-Symptomatic Disease in Lung Health and Disease (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.838 — Lung Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Oct 03, 2014
Last Updated Date:
Original Closing Date for Applications: Jan 21, 2015
Current Closing Date for Applications: Jan 21, 2015
Archive Date: Feb 21, 2015
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
City or township governments
Public and State controlled institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
State governments
County governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this FOA is to invite applications that will seek to prospectively define and/or validate pulmonary or immune system attributes associated with pre-symptomatic disease states or resilience, with the goal of informing the development of primary prevention strategies for chronic lung diseases.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-15-024.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.838 FORMS-C FORMS-C PKG00208183 Dec 21, 2014 Jan 21, 2015 View

Package 1

Mandatory forms

267948 RR_SF424_2_0-2.0.pdf

267948 PHS398_ResearchPlan_2_0-2.0.pdf

267948 PHS398_CoverPageSupplement_2_0-2.0.pdf

267948 RR_KeyPersonExpanded_2_0-2.0.pdf

267948 RR_OtherProjectInfo_1_3-1.3.pdf

267948 PerformanceSite_2_0-2.0.pdf

Optional forms

267948 RR_SubawardBudget30_1_3-1.3.pdf

267948 PlannedReport-1.0.pdf

267948 PHS398_CumulativeInclusionReport-1.0.pdf

267948 PHS398_ModularBudget_1_2-1.2.pdf

267948 RR_Budget_1_3-1.3.pdf

2025-07-09T19:12:32-05:00

Share This Post, Choose Your Platform!

About the Author: